Project Details
Description
Phase III Clinical Trial to Evaluate the Efficacy of Bevacizumab with Tarceva for Non-Small Cell Lung Cancer after failure of First Line Chemotherapy
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/05 → 2/28/11 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.